Description
FLU VACCINE
First action · last action
2017-03-30 · 2017-03-30
Transactions
1
First transaction's obligation
$319,475
Base + all options value (sum of deltas)
$319,475
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
Parent IDV
VA797P17C0019
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-30+$319,475= $319,475
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-30 | +$319,475 | $319,475 | FLU VACCINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FRHTPHMZMX47)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0030 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C77024F0047 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $3,166 | FY2024 |
| 36C24124F0121 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $39,180 | FY2024 |
| 36C24124F0119 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $33,793 | FY2024 |
| 36C24624N0685 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $58,770 | FY2024 |
| 36C24624N0682 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $19,590 | FY2024 |
Other recipients under 6505 from 688-WASHINGTON DC (00688)(36C688) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24517F2371 | SANOFI VACCINES US INC. | 688-WASHINGTON DC (00688)(36C688) | $13,375 | FY2017 |
| VA24517P0138 | MCKESSON PLASMA AND BIOLOGICS LLC | 688-WASHINGTON DC (00688)(36C688) | $22,192 | FY2017 |
| VA24516P1170 | ASD SPECIALTY HEALTHCARE, LLC | 688-WASHINGTON DC (00688)(36C688) | $11,493 | FY2016 |
| VA24516P1167 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 688-WASHINGTON DC (00688)(36C688) | $6,294 | FY2016 |
| VA24516J1046 | BAXTER HEALTHCARE CORPORATION | 688-WASHINGTON DC (00688)(36C688) | $12,954 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24517F2367_3600_VA797P17C0019_3600 · retrieved 2026-09-26.